622. Lymphomas: Translational Non-Genetic: Poster II

Single-cell atlas of circulating immunity identifies shared specific DLBCL signatures predicting response to R-CHOP and CD19 CAR-t therapies

A unified spatial & molecular atlas of anatomically restricted large B-cell lymphomas defines stereotyped cell ecosytems

Thyroid hormones enhance the responsiveness of T-cell lymphomas to romidepsin

Multimodal single-cell and spatial analyses reveal a distinct immune ecosystem in pediatric classic Hodgkin lymphoma

Baseline intratumoral CD4? T-cell abundance and frequency correlates with durable clinical response to acalabrutinib, venetoclax, and obinutuzumab (AVO) treatment in Mantle Cell Lymphoma

From mechanistic synergy to clinical breakthrough: Updated results from a phase II Trial of HD-MTX, selinexor, and zanubrutinib in CNS lymphoma

Lisocabtagene maraleucel (liso-cel) demonstrates superior efficacy across inflammatory risk subgroups in second-line (2L) large B-cell lymphoma (LBCL): A retrospective analysis of the TRANSFORM study

Single-cell metabolic profiling of T cells identifies a fitness signature associated with early CAR T failure in large B cell lymphoma

Exposure to epcoritamab is associated with improved T-cell functionality and dynamic changes in CD8+ T-cells in diffuse large B-cell lymphoma: Insights from epcore NHL-6

Phenotype and functional state of endogenous T-cells support T-cell engager therapy in the post-CAR T therapy setting

Machine learning models improve survival prediction in DLBCL: Analysis from the goya trial

Integrative analysis of the tumour immune microenvironment of breast implant-associated anaplastic large cell lymphoma using multi-omics

Lactate promotes DLBCL progression via NAT10/ldha axis and immune suppression

Clinical impact of untargeted baseline plasma metabolomics in newly diagnosed diffuse large B-cell lymphoma

Ruxolitinib increases immunogenicity and primes the tumor microenvironment for immune checkpoint blockade in 9p24.1 amplified lymphomas